SCOPE is a premier event for Clinical Operations with a program focused on all aspects of clinical trial planning, management, and operations. This year’s agenda will feature 3 plenary sessions along with a focus on hot topics such as Recruitment & Engagement, Real-World Evidence, and Biomarkers.
ERT’s Chris Watson, PhD, Director of Product Strategy will be presenting The role of emerging technology in improving the patient experience and generating PROs on February 21st at 11:30am. In this presentation, Chris will discuss how the real-world data generated through Patient Reported Outcomes play an increasingly important role across the Drug Development Lifecycle. In a hyper-connected world, learn how patients’ own technologies enable effective ways of capturing ‘new data’ to deliver high-quality PROs.
Visit booth #510 to meet with Chris and our team to discuss real-world evidence and more!